AIMEE JAQUELYN PEREZ: Open Payments
NPI 1801324892 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 68 payments from 14 companies in 2025. Trend: 2023 $853 · 2024 $1,594 · 2025 $1,371
Food & beverage: $1,286Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $305 |
| ABBVIE INC. | 11 | $190 |
| Ardelyx, Inc. | 8 | $171 |
| Madrigal Pharmaceuticals | 12 | $158 |
| GENZYME CORPORATION | 4 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
| PFIZER INC. | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| RedHill Biopharma Inc. | 1 | $35 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, MAVYRET, DUPIXENT, XIFAXAN, XELJANZ, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
